Melanie Bremm

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol

Ulrike Koehl, Claudia Brehm, Sabine Huenecke et al. · Frontiers in Oncology · 2013 · 139 citations · Full text

Life Sciences, Hematology, Immunology +17

IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study

Claudia Brehm, Sabine Huenecke, Andrea Quaiser et al. · PLoS ONE · 2011 · 90 citations · Full text

Life Sciences, Hematology, Immunology +17

The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation

Annekathrin Heinze, Beatrice Grebe, Melanie Bremm et al. · Frontiers in Immunology · 2019 · 62 citations · Full text

Life Sciences, Immunology, Oncology +17

Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel

Andreas Peinelt, Melanie Bremm, Hermann Kreyenberg et al. · Frontiers in Immunology · 2022 · 50 citations · Full text

Life Sciences, Hematology, Immunology +15

Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation

Evelyn Ullrich, Emilia Salzmann‐Manrique, Shahrzad Bakhtiar et al. · Frontiers in Immunology · 2016 · 43 citations · Full text

Life Sciences, Hematology, Immunology +12